Quanterix (QTRX) Expected to Announce Quarterly Earnings on Thursday

Key Points

• Quanterix is set to announce its Q2 2025 earnings on August 7th, with analysts expecting a loss of ($0.45) per share and revenues of $29.73 million.
• The company's last reported earnings showed a smaller loss than expected, with a negative net margin of 36.82% and a P/E ratio of -4.44.
• Institutional investors own 86.48% of Quanterix's stock, with notable purchases by firms like AQR Capital Management and Goldman Sachs in recent quarters.

Quanterix (NASDAQ:QTRX - Get Free Report) is projected to announce its Q2 2025 earnings results after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of ($0.41) per share and revenue of $29.73 million for the quarter. Quanterix has set its FY 2025 guidance at EPS.

Quanterix (NASDAQ:QTRX - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.06). Quanterix had a negative net margin of 56.04% and a negative return on equity of 17.90%. The company had revenue of $24.48 million during the quarter, compared to the consensus estimate of $29.73 million. On average, analysts expect Quanterix to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Quanterix Stock Performance

QTRX stock traded down $0.76 during midday trading on Friday, hitting $4.75. The company had a trading volume of 1,912,251 shares, compared to its average volume of 696,722. Quanterix has a 52 week low of $4.05 and a 52 week high of $15.85. The stock's 50 day moving average price is $5.98 and its 200 day moving average price is $6.37.

Insiders Place Their Bets

In other news, Director David R. Walt acquired 131,869 shares of the firm's stock in a transaction on Friday, June 6th. The stock was acquired at an average price of $5.43 per share, for a total transaction of $716,048.67. Following the completion of the acquisition, the director owned 1,628,802 shares in the company, valued at $8,844,394.86. This trade represents a 8.81% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William P. Donnelly acquired 93,113 shares of the firm's stock in a transaction on Friday, June 6th. The stock was purchased at an average price of $5.44 per share, with a total value of $506,534.72. Following the acquisition, the director owned 139,094 shares of the company's stock, valued at $756,671.36. This represents a 202.50% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 463,113 shares of company stock valued at $2,625,444. 6.90% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Quanterix

A number of institutional investors have recently modified their holdings of QTRX. AQR Capital Management LLC grew its stake in shares of Quanterix by 204.4% in the first quarter. AQR Capital Management LLC now owns 98,990 shares of the company's stock worth $644,000 after acquiring an additional 66,470 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Quanterix by 20.6% in the first quarter. Goldman Sachs Group Inc. now owns 349,696 shares of the company's stock worth $2,277,000 after acquiring an additional 59,655 shares during the last quarter. Royal Bank of Canada grew its stake in shares of Quanterix by 26.3% in the first quarter. Royal Bank of Canada now owns 170,745 shares of the company's stock worth $1,112,000 after acquiring an additional 35,509 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Quanterix by 2.4% in the second quarter. Geode Capital Management LLC now owns 887,080 shares of the company's stock worth $5,900,000 after acquiring an additional 21,210 shares during the last quarter. Finally, Jane Street Group LLC grew its stake in shares of Quanterix by 4.2% in the first quarter. Jane Street Group LLC now owns 58,313 shares of the company's stock worth $380,000 after acquiring an additional 2,366 shares during the last quarter. 86.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on QTRX. Wall Street Zen downgraded Quanterix from a "hold" rating to a "sell" rating in a report on Thursday, May 22nd. Leerink Partners restated a "market perform" rating and set a $8.00 target price (down previously from $12.00) on shares of Quanterix in a report on Wednesday, April 30th. Leerink Partnrs downgraded Quanterix from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Finally, Canaccord Genuity Group decreased their target price on Quanterix from $15.00 to $12.00 and set a "buy" rating for the company in a report on Tuesday, May 13th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $13.50.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.